The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial Infarction

Chronic LIT01-196 treatment post MI improves LV function without decreasing blood pressure, increases cardiac vascular density, and reduces cardiac remodelling. This suggests that apelin receptor activation by LIT01-196 might constitute an original pharmacological approach for HF treatment after MI.

Authors

Institutions

Publication Details

Journal
Canadian Journal of Cardiology
Published
2024-12-12
DOI
https://doi.org/10.1016/j.cjca.2024.11.034
Citations
4
Primary Topic
Apelin-related biomedical research
Type
article
Field-Weighted Citation Impact
1.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial Infarction

Ara Parlakian, Stéphanie Riché, Nadia De Mota, François Daubeuf et al.
4 citations
Canadian Journal of Cardiology
Apelin-related biomedical research
1.79
article

The Metabolically Resistant Apelin-17 Analogue LIT01-196 Reduces Cardiac Dysfunction and Remodelling in Heart Failure After Myocardial Infarction

Ara Parlakian, Stéphanie Riché, Nadia De Mota, François Daubeuf, Solène Emmanuelle Boitard, Dominique Bonnet, Xavier Iturrioz, Catherine Llorens‐Cortés, Onnik Agbulut, Pierre-Emmanuel Girault-Sotias, Robin Deloux, Alain Berdeaux
article en
4 citations

Abstract

Chronic LIT01-196 treatment post MI improves LV function without decreasing blood pressure, increases cardiac vascular density, and reduces cardiac remodelling. This suggests that apelin receptor activation by LIT01-196 might constitute an original pharmacological approach for HF treatment after MI.

Canadian Journal of CardiologyVol. 41(5)
Twitter (United States) (US), Centre National de la Recherche Scientifique (FR), Inserm (FR), Collège de France (FR), Université Paris-Est Créteil (FR), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), Sorbonne Université (FR), Technologies pour la Santé (FR), Institut de Biologie Paris-Seine (FR), Centre Interdisciplinaire de Recherche en Biologie (FR), Laboratoire d'Innovation Thérapeutique (FR), CEA Paris-Saclay (FR), Institut Mondor de Recherche Biomédicale (FR), Adaptation Biologique et Vieillissement (FR), Développement Adaptation et Vieillissement (FR), Université de Strasbourg (FR)
Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Fédération Française de Cardiologie, Centre National de la Recherche Scientifique, Université Paris-Saclay, Fondation du Collège de France, Sorbonne Université, Collège de France
Good health and well-being
Openalex Percentile: Top 14%
Apelin-related biomedical research
1.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.